YNAJF yields 3.16% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, YNAJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YNAJF + JNJ for your $10,000?
Yantai North Andre Juice Co., Ltd. manufactures and sells various fruit and vegetable juices, fruit pulp, essence, pomace, biological feed, and related products in China. It also manufactures fruit and vegetable beverages, apple juice concentrate, pear juice concentrate, peach puree and juice, haw juice concentrate, sweet potato juice concentrate, strawberry puree and juice concentrate, apple fructose, pear fructose, drinking water, cloudy apple juice, and other products. In addition, the company manufactures iron drums for juice outer packaging; purchases agricultural and sideline products; imports and exports goods and technology; and manufactures and sells of lemon and orange juice, lemon oil and essence, and orange oil and essence. Further, it is involved in the biological comprehensive utilization of apple essence, pomace, vegetables, and other products; import and export of juice and pulp; and provision of goods storage services. The company also exports its products to rest of Asia, Europe, North America, Africa, Oceania, and South America. The company was founded in 1996 and is headquartered in Yantai, the People's Republic of China.
Full YNAJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.